glp 1 thyroid nodule GLP-1 receptor agonist use for more than year may increase cancer risk Thyroid nodules holding you back

launch expected early January 2026

Note: No significant changes in bone turnover markers (osteocalcin and bone-specific alkaline phosphatase) were observed in studies (PMID: 10373343, PMID: 10828840)

Anecdotally, some users report that the appetite-suppressing effects weaken over time, necessitating dosage adjustments to sustain efficacy. The impact of GLP-1 use extends beyond just calorie-dense products, with most categories experiencing declines

Given the smaller sample size of children with Stage 2, we next combined the most severe stages (2 and 3) and assessed differences in GPx3 concentration, to increase statistical confidence